A model to explain how the Bacille Calmette Guérin (BCG) vaccine drives interleukin-12 production in neonates

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Kativhu, Chido Loveness ^a   Libraty, Daniel H ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BCG VACCINE; CD16 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TLR2 PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; MONOCYTE DERIVED DENDRITIC CELL; NATURAL KILLER CELL; NEWBORN; PLASMACYTOID DENDRITIC CELL; UMBILICAL CORD; UPREGULATION; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; FETUS BLOOD; FLOW CYTOMETRY; GENETICS; METABOLISM; MONONUCLEAR CELL;

BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; INFANT, NEWBORN; INTERLEUKIN-12; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2;

EID: 84990232700     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162148     Document Type: Article

References (44)

1. Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol. 1999; 163(4):2249-55. PMID: 10438968.
2. Vekemans J, Amedei A, Ota MO, D'Elios MM, Goetghebuer T, Ismaili J, et al. Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol. 2001; 31(5):1531-5. Epub 2001/07/24. doi: 10.1002/1521-4141(200105)31:5〈1531::AID-IMMU1531〉3.0.CO;2-1 PMID: 11465110.
3. Akkoc T, Aydogan M, Yildiz A, Karakoc-Aydiner E, Eifan A, Keles S, et al. Neonatal BCG vaccination induces IL-10 production by CD4+ CD25+ T cells. Pediatr Allergy Immunol. 2010; 21(7):1059-63. doi: 10.1111/j.1399-3038.2010.01051.x PMID: 20977501.
4. Hussey GD, Watkins ML, Goddard EA, Gottschalk S, Hughes EJ, Iloni K, et al. Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology. 2002; 105(3):314-24. Epub 2002/03/29. PMID: 11918693; PubMed Central PMCID: PMC1782661.
5. Jensen KJ, Larsen N, Biering-Sorensen S, Andersen A, Eriksen HB, Monteiro I, et al. Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial. J Infect Dis. 2015; 211(6):956-67. doi: 10.1093/infdis/jiu508 PMID: 25210141; PubMed Central PMCID: PMCPMC4340366.
6. Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM, et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis. 2011; 204(2):245-52. doi: 10.1093/infdis/jir240 PMID: 21673035.
7. Shann F. Commentary: BCG vaccination halves neonatal mortality. Pediatr Infect Dis J. 2012; 31 (3):308-9. Epub 2012/02/15. doi: 10.1097/INF.0b013e3182465be8 00006454-201203000-00022 [pii]. PMID: 22330168.
8. Higgins JPT, Soares-Weiser K, Reingold A. Systematic review of the non-specific effects of BCG, DPT and measles containing vaccines. Review. World Health Organization: 2014 13 March 2014. Report No.
9. Goodridge HS, Ahmed SS, Curtis N, Kollmann TR, Levy O, Netea MG, et al. Harnessing the beneficial heterologous effects of vaccination. Nat Rev Immunol. 2016; 16(6):392-400. doi: 10.1038/nri.2016.43 PMID: 27157064.
10. Libraty DH, Zhang L, Woda M, Acosta LP, Obcena A, Brion JD, et al. Neonatal BCG vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines. Trials Vaccinol. 2014; 3:1-5. doi: 10.1016/j.trivac.2013.11.004 PMID: 24611083; PubMed Central PMCID: PMC3943168.
11. Organization WH. Systematic Review of the Non-specific Immunological Effects of Selected Routine Childhood Immunizations. 2014 13.03.2014. Report No.
12. de Castro MJ, Pardo-Seco J, Martinon-Torres F. Nonspecific (Heterologous) Protection of Neonatal BCG Vaccination Against Hospitalization Due to Respiratory Infection and Sepsis. Clin Infect Dis. 2015; 60(11):1611-9. doi: 10.1093/cid/civ144 PMID: 25725054.
13. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol Today. 1993; 14 (7):335-8. doi: 10.1016/0167-5699(93)90230-I PMID: 8103338.
14. Wu CY, Demeure C, Kiniwa M, Gately M, Delespesse G. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J Immunol. 1993; 151(4):1938-49. PMID: 8102154.
15. Barrios C, Brawand P, Berney M, Brandt C, Lambert PH, Siegrist CA. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol. 1996; 26(7):1489-96. PMID: 8766551.
16. Lee SM, Suen Y, Chang L, Bruner V, Qian J, Indes J, et al. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood. 1996; 88(3):945-54. PMID: 8704253.
17. Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, Wang XY, et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol. 2009; 183(11):7150-60. PMID: 19917677. doi: 10.4049/jimmunol.0901481
18. Basha S, Surendran N, Pichichero M. Immune responses in neonates. Expert Rev Clin Immunol. 2014; 10(9):1171-84. doi: 10.1586/1744666X.2014.942288 PMID: 25088080; PubMed Central PMCID: PMCPMC4407563.
19. Debock I, Flamand V. Unbalanced Neonatal CD4(+) T-Cell Immunity. Front Immunol. 2014; 5:393. doi: 10.3389/fimmu.2014.00393 PMID: 25221551; PubMed Central PMCID: PMCPMC4145351.
20. Morris MC, Surendran N. Neonatal Vaccination: Challenges and Intervention Strategies. Neonatology. 2016; 109(3):161-9. doi: 10.1159/000442460 PMID: 26757146; PubMed Central PMCID: PMCPMC4749499.
21. Ritz N, Mui M, Balloch A, Curtis N. Non-specific effect of Bacille Calmette-Guerin vaccine on the immune response to routine immunisations. Vaccine. 2013; 31(30):3098-103. Epub 2013/04/16. S0264-410X(13)00405-2 [pii] doi: 10.1016/j.vaccine.2013.03.059 PMID: 23583897.
22. Goriely S, Vincart B, Stordeur P, Vekemans J, Willems F, Goldman M, et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol. 2001; 166(3):2141-6. Epub 2001/02/13. PMID: 11160266.
23. Goriely S, Van Lint C, Dadkhah R, Libin M, De Wit D, Demonte D, et al. A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J Exp Med. 2004; 199(7):1011-6. Epub 2004/03/31. doi: 10.1084/jem.20031272 [pii]. PMID: 15051764; PubMed Central PMCID: PMC2211877.
24. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008; 42(2):145-51. doi: 10.1016/j.cyto.2008.01.006 PMID: 18304834.
25. Kim Y, Choi Y, Jeon BY, Jin H, Cho SN, Lee H. A simple and efficient multiplex PCR assay for the identification of Mycobacterium genus and Mycobacterium tuberculosis complex to the species level. Yonsei Med J. 2013; 54(5):1220-6. doi: 10.3349/ymj.2013.54.5.1220 PMID: 23918573; PubMed Central PMCID: PMCPMC3743195.
26. Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol. 2011; 29:163-83. doi: 10.1146/annurev-immunol-031210-101345 PMID: 21219184; PubMed Central PMCID: PMCPMC4160806.
27. Uze G, Schreiber G, Piehler J, Pellegrini S. The receptor of the type I interferon family. Curr Top Microbiol Immunol. 2007; 316:71-95. PMID: 17969444.
28. Esin S, Counoupas C, Aulicino A, Brancatisano FL, Maisetta G, Bottai D, et al. Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2. Scand J Immunol. 2013; 77(6):460-9. doi: 10.1111/sji.12052 PMID: 23578092.
29. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 1999; 285(5428):732-6. PMID: 10426995.
30. Gilleron M, Quesniaux VF, Puzo G. Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette Guerin and mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response. J Biol Chem. 2003; 278(32):29880-9. doi: 10.1074/jbc.M303446200 PMID: 12775723.
31. Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle J, Golenbock DT, et al. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol. 2001; 167(2):910-8. PMID: 11441098.
32. Pecora ND, Gehring AJ, Canaday DH, Boom WH, Harding CV. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J Immunol. 2006; 177 (1):422-9. PMID: 16785538.
33. Quesniaux VJ, Nicolle DM, Torres D, Kremer L, Guerardel Y, Nigou J, et al. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol. 2004; 172(7):4425-34. PMID: 15034058.
34. Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol. 2004; 173(4):2660-8. PMID: 15294983.
35. von Meyenn F, Schaefer M, Weighardt H, Bauer S, Kirschning CJ, Wagner H, et al. Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guerin by Flt3-ligand generated dendritic cells. Immunobiology. 2006; 211(6-8):557-65. Epub 2006/08/22. S0171-2985(06)00062-3 [pii] doi: 10.1016/j.imbio.2006.05.004 PMID: 16920494.
36. Uehori J, Matsumoto M, Tsuji S, Akazawa T, Takeuchi O, Akira S, et al. Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guerin peptidoglycan. Infect Immun. 2003; 71(8):4238-49. PMID: 12874299; PubMed Central PMCID: PMCPMC165983.
37. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124(4):783-801. doi: 10.1016/j.cell.2006.02.015. PMID: 16497588.
38. Milstien JB, Gibson JJ. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull World Health Organ. 1990; 68(1):93-108. PMID: 2189588; PubMed Central PMCID: PMCPMC2393003.
39. Zhang X, Casartelli N, Lemoine S, Mozeleski B, Azria E, Le Ray C, et al. Plasmacytoid dendritic cells engagement by influenza vaccine as a surrogate strategy for driving T-helper type 1 responses in human neonatal settings. J Infect Dis. 2014; 210(3):424-34. doi: 10.1093/infdis/jiu103 PMID: 24558121.
40. Eljaafari FM, Takada H, Tanaka T, Doi T, Ohga S, Hara T. Potent induction of IFN-gamma production from cord blood NK cells by the stimulation with single-stranded RNA. Journal of clinical immunology. 2011; 31(4):728-35. doi: 10.1007/s10875-011-9528-4 PMID: 21487893.
41. Lauzon NM, Mian F, MacKenzie R, Ashkar AA. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell Immunol. 2006; 241(2):102-12. doi: 10.1016/j.cellimm.2006.08.004 PMID: 17049504.
42. Souza-Fonseca-Guimaraes F, Adib-Conquy M, Cavaillon JM. Natural killer (NK) cells in antibacterial innate immunity: angels or devils? Mol Med. 2012; 18:270-85. doi: 10.2119/molmed.2011.00201 PMID: 22105606; PubMed Central PMCID: PMCPMC3324953.
43. Osugi Y, Hara J, Kurahashi H, Sakata N, Inoue M, Yumura-Yagi K, et al. Age-related changes in surface antigens on peripheral lymphocytes of healthy children. Clinical and experimental immunology. 1995; 100(3):543-8. PMID: 7774067; PubMed Central PMCID: PMCPMC1534469.
44. Watkins ML, Semple PL, Abel B, Hanekom WA, Kaplan G, Ress SR. Exposure of cord blood to Mycobacterium bovis BCG induces an innate response but not a T-cell cytokine response. Clin Vaccine Immunol. 2008; 15(11):1666-73. Epub 2008/09/26. CVI.00202-08 [pii] doi: 10.1128/CVI.00202-08 PMID: 18815231; PubMed Central PMCID: PMC2583525.